Furthermore, our findings revealed that IL12p40 signaling had a key impact on the functions of human CD4+ T cells, which might be an important part of IBD pathogenesis and the mechanisms why anti-IL12p40 treatment presented efficacy in CD. Here, CD4 is linked to inflammatory bowel disease.